Lipoproteins and the endothelium: Past, present and future

Hellenic Journal of Cardiology

Volumn 47, Issue 3, 2006, Pages 158-159

  Lee, Justin ^a,b   Leeson, Paul C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Endothelium; Hypercholesterolaemia; Inflammation

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; LIPID ANALYSIS; NOTE; PROTEIN ANALYSIS; VASCULAR ENDOTHELIUM; VASODILATATION; ATHEROSCLEROSIS; BLOOD; PHYSIOLOGY; RISK ASSESSMENT;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; RISK ASSESSMENT;

EID: 35348931198     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Note

References (19)

1. Antoniades C, Tousoulis D, Marinou K, et al: Effects of lipid profile on forearm hyperemic response in young subjects. Hellenic J Cardiol 2006; 47: 152-157.
2. Walldius G, Jungner I, Holme I, et al: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026.
3. Yusuf PS, Hawken S, Ounpuu S, et al: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
4. Williams KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15: 551-561.
5. Celermajer DS, Sorensen KE, Gooch VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
6. Halcox JP, Schenke WH, Zalos G, et al: Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658.
7. Heitzer T, Schlinzig T, Krohn K, et al: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
8. Elovson J, Chatterton JE, Bell GT, et al: Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 1988; 29: 1461-1473.
9. Anber V, Griffin BA, McConnell M, et al: Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996; 124: 261.
10. Kolovou GD, Anagnostopoulou KK, Cokkinos DV: Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad Med J 2005; 81: 358-366.
11. Ridker PM, Rifai N, Cook NR, et al: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005; 294: 326-333.
12. Gordon T, Castelli WP, Hjortland MC, et al: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-714.
13. Lee JM, Choudhury RP: Prospects for atherosclerosis regression: HDL elevation and other emerging therapeutic technologies. Heart 2006. (online first - http://heart.bmjjournals.com/)
14. Nicholls SJ, Dusting GJ, Cutri B, et al: Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 2005; 111: 1543-1550.
15. Garner B, Waldeck AR, Witting PK, et al: Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem 1998; 273: 6088-6095.
16. Spieker LE, Sudano I, Hurlimann D, et al: High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002; 105: 1399-1402.
17. Gofman JW, Lindgren F: The role of lipids and lipoproteins in atherosclerosis. Science 1950; 111: 166-171.
18. Choudhury RP, Fuster V, Fayad ZA: Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 2004; 3: 913-925.
19. Nissen SE, Tsunoda T, Tuzcu EM, et al: Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290: 2292-2300.